Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

Clinical trial NCT03133234 · COMPLETED

Trial details

NCT number: NCT03133234
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

T790M Positive NSCLC Patients

Start date: 2017-05-23
Primary completion: 2017-09-13
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.